Nicotinamide adenine dinucleotide
Nicotinamide adenine dinucleotide or NAD or NADH is a coenzyme found in all living cells. Nicotinamide adenine dinucleotide exists in two forms, an oxidized and reduced form abbreviated as NAD+ and NADH respectively.
Evidence[edit | edit source]
Notable studies[edit | edit source]
- 2016, Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I-Mutant Fibroblasts
- 2010, Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia
- 2004, Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome - (Full text)
- 1999, Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome - (Full text)
Blogs and articles[edit | edit source]
- 2016, NAD+ and SIRT1: Their Role In Chronic Health Issues (see also SIRT1)
- 2015, Beyond Resveratrol: The Anti-Aging NAD Fad
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- Porter, Nicole S.; Jason, Leonard A.; Boulton, Aaron; Bothne, Nancy; Coleman, Blair (Mar 2010). "Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia" (PDF). Journal of Alternative and Complementary Medicine (New York, N.Y.). 16 (3): 235–249. doi:10.1089/acm.2008.0376. ISSN 1557-7708. PMID 20192908.
- Santaella, ML; Font, I; Disdier, OM (Jun 2004). "Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome". Puerto Rico health sciences journal. pp. 89–93. PMID 15377055.
- Forsyth, Linda M; Preuss, Harry G; MacDowell, Ana L; Chiazze, Leonard; Birkmayer, George D; Bellanti, Joseph A (Feb 1, 1999). "Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome". Annals of Allergy, Asthma & Immunology. 82 (2): 185–191. doi:10.1016/S1081-1206(10)62595-1. ISSN 1081-1206.
α - Greek letter alpha or alfa (symbol)
chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue (idiopathic chronic fatigue) without additional symptoms. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.